Eduardo M. Rego

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 165 publications

Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.

Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.

Journal: European journal of pharmacology

Published: February 21, 2026

Evaluating Risk Factors for Early Mortality in Adult ALL in Brazil.

Evaluating Risk Factors for Early Mortality in Adult ALL in Brazil.

Journal: JCO global oncology

Published: February 04, 2026

Exploring the prognostic impact and biological functions of mutant-like TP53-related genes in acute myeloid leukemia.

Exploring the prognostic impact and biological functions of mutant-like TP53-related genes in acute myeloid leukemia.

Journal: Hematology, transfusion and cell therapy

Published: November 24, 2025

SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL).

SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL).

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 04, 2025

Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches.

Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches.

Journal: Blood research

Published: October 02, 2025

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 02, 2025

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Journal: Haematologica

Published: September 08, 2025

International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

Journal: Nature communications

Published: June 10, 2025

Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia.

Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: June 08, 2025

Randomized, Placebo-Controlled, Triple-Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline-Based Cancer Therapy.

Randomized, Placebo-Controlled, Triple-Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline-Based Cancer Therapy.

Journal: Journal of the American Heart Association

Published: May 13, 2025

Challenges in evaluating thromboembolic risk in acute leukemia: clinical profiling and limitations of current scoring systems.

Challenges in evaluating thromboembolic risk in acute leukemia: clinical profiling and limitations of current scoring systems.

Journal: Research and practice in thrombosis and haemostasis

Published: April 10, 2025

What Is Acute Myeloid Leukemia?

What Is Acute Myeloid Leukemia?

Journal: EJHaem

Published: March 26, 2025

Showing 1-12 of 165

Last Updated: 09/26/2026